MarketPeel
Insider Trading Intelligence
KC

Kent Douglas Cunningham

SRXH
CHIEF EXECUTIVE OFFICER · SRX HEALTH SOLUTIONS, INC. · CIK 0002097408
FILING MIX · LIFETIME100%/0%
BUYS
9
SELLS
0
TOTAL VALUE
$735.0K
COMPANIES
1
ACTIVE SINCE
Jun 2024
HOLDINGS NOW
63
AVG SELL PX
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Kent Douglas Cunningham. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
SRXH · 63 shares · as of Mar 16, 2026
0163,765327,530491,295655,06020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 9 buys / 0 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
247,522$0.32$78.8K247,522Mar 16, 2026Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
63$800.00$50.4K63Mar 16, 2026Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
200,000$0.39$78.0K655,060Dec 3, 2025Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
44,464$0.33$14.7K455,060Sep 26, 2025Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
231,193$0.40$93.4K410,596Aug 25, 2025Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
84,906$1.59$135.0K179,403Apr 25, 2025Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
71,770$2.09$150.0K94,497Apr 24, 2025Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
8,000$5.00$40.0K8,000Jun 26, 2024Apr 3, 2026
SRXH
SRX HEALTH SOLUTIONS, INC.
PURCHASEGRANT
Stock grant
22,727$4.17$94.8K22,727Jun 26, 2024Apr 3, 2026
Other insiders · SRXH
Loading peer insiders…
About this filer
CIK 0002097408
ROLE
Chief Executive Officer
PRIMARY
SRXH
COMPANIES
1
ACTIVE SINCE
Jun 2024
MARKETPEEL · /INSIDER/0002097408DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback